Cargando…
Prognostic utility of NT-proBNP greater than 70,000 pg/mL in patients with end stage renal disease
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Science Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198270/ https://www.ncbi.nlm.nih.gov/pubmed/30364747 http://dx.doi.org/10.11909/j.issn.1671-5411.2018.07.002 |
_version_ | 1783364934994755584 |
---|---|
author | Perez-Downes, Julio Palacio, Carlos Ibrahim, Saif Shelley, Patrisha Miller, Alan Reddy, Pramod |
author_facet | Perez-Downes, Julio Palacio, Carlos Ibrahim, Saif Shelley, Patrisha Miller, Alan Reddy, Pramod |
author_sort | Perez-Downes, Julio |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6198270 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Science Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-61982702018-10-24 Prognostic utility of NT-proBNP greater than 70,000 pg/mL in patients with end stage renal disease Perez-Downes, Julio Palacio, Carlos Ibrahim, Saif Shelley, Patrisha Miller, Alan Reddy, Pramod J Geriatr Cardiol Perspective Science Press 2018-07 /pmc/articles/PMC6198270/ /pubmed/30364747 http://dx.doi.org/10.11909/j.issn.1671-5411.2018.07.002 Text en Institute of Geriatric Cardiology http://creativecommons.org/licenses/by-nc-sa/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License, which allows readers to alter, transform, or build upon the article and then distribute the resulting work under the same or similar license to this one. The work must be attributed back to the original author and commercial use is not permitted without specific permission. |
spellingShingle | Perspective Perez-Downes, Julio Palacio, Carlos Ibrahim, Saif Shelley, Patrisha Miller, Alan Reddy, Pramod Prognostic utility of NT-proBNP greater than 70,000 pg/mL in patients with end stage renal disease |
title | Prognostic utility of NT-proBNP greater than 70,000 pg/mL in patients with end stage renal disease |
title_full | Prognostic utility of NT-proBNP greater than 70,000 pg/mL in patients with end stage renal disease |
title_fullStr | Prognostic utility of NT-proBNP greater than 70,000 pg/mL in patients with end stage renal disease |
title_full_unstemmed | Prognostic utility of NT-proBNP greater than 70,000 pg/mL in patients with end stage renal disease |
title_short | Prognostic utility of NT-proBNP greater than 70,000 pg/mL in patients with end stage renal disease |
title_sort | prognostic utility of nt-probnp greater than 70,000 pg/ml in patients with end stage renal disease |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198270/ https://www.ncbi.nlm.nih.gov/pubmed/30364747 http://dx.doi.org/10.11909/j.issn.1671-5411.2018.07.002 |
work_keys_str_mv | AT perezdownesjulio prognosticutilityofntprobnpgreaterthan70000pgmlinpatientswithendstagerenaldisease AT palaciocarlos prognosticutilityofntprobnpgreaterthan70000pgmlinpatientswithendstagerenaldisease AT ibrahimsaif prognosticutilityofntprobnpgreaterthan70000pgmlinpatientswithendstagerenaldisease AT shelleypatrisha prognosticutilityofntprobnpgreaterthan70000pgmlinpatientswithendstagerenaldisease AT milleralan prognosticutilityofntprobnpgreaterthan70000pgmlinpatientswithendstagerenaldisease AT reddypramod prognosticutilityofntprobnpgreaterthan70000pgmlinpatientswithendstagerenaldisease |